Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Trends Neurosci. 2013 Dec 30;37(2):95–105. doi: 10.1016/j.tins.2013.11.005

Table 2.

Recurrent disruptive mutations in ID and ASD

Genea,b ID cases ASD cases Summaryc,d,e ESP samples
Variants Frequency
CHD8 9/2446 2 (O), 7 (O*) [+3 (N*)] 0 0/6503
SCN2A 3/151 2/593 1 (L), 2 (R), 2 (S) [+1 (N*)] 1 7/6503
SYNGAP1 3/151 1 (L), 2 (R) 1 207/6503f
GRIN2B 3/2446 1 (O), 2 (O*) 0 0/6503
DYRK1A 3/2446 1 (I), 1 (O), 1 (O*) 0 0/6503
ZNF292 1/151 1/593 1 (L), 1 (N) 1 2/6503
POGZ 2/593 1 (I), 1 (N) 1 1/6503
KATNAL2 2/593 1 (O), 1 (S) 1 1/6503
TBR1 2/2446 1 (O), 1 (O*) 0 0/6503
CTNNB1 1/151 1/2446 1 (L), 1 (O*), [+1 (L*)] 0 0/6503
SETBP1 1/151 1/593 1 (O), 1 (R) 3 58/6503f
ADNP 2/2446 1 (O), 1 (O*) 1 1/6500
LRP2 1/151 1/593 1 (I), 1 (L) 6 53/6500
ARID1B 2/2446 1 (O), 1 (O*) 5 314/6500
a

Genes with two or more de novo truncating mutations observed in studies of ASD or ID are listed.

b

Additional abbreviations: KATNAL2, katanin p60 subunit A-like 2; LRP2, low density lipoprotein receptor-related protein 2; POGZ, pogo transposable element with ZNF domain; ZNF292, zinc finger protein 292.

c

The summary indicates studies in which mutations were discovered.

d

I, Iossifov et al. [26]; L, de Ligt et al. [28]; N, Neal et al. [25], O and O*: O’Roak et al. [24,44]; R, Rauch et al. [29]; S, Sanders et al. [27].

e

Mutations found in secondary replication screens or case-control studies are indicated in [brackets] with starred (*) reference. Truncating events found in the Exome Sequencing Project (ESP) database and their population frequencies are shown.

f

The truncating variants found in the ESP database in SYNGAP1 and SETBP1 genes fell at the extreme 3′ end of the gene, suggesting that they do not adversely affect gene function